WPI 3704 (Armodafinil 200 mg)
Pill with imprint WPI 3704 is White, Capsule-shape and has been identified as Armodafinil 200 mg. It is supplied by Watson Laboratories, Inc.
Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; obstructive sleep apnea/hypopnea syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3704
Armodafinil
- Imprint
- WPI 3704
- Strength
- 200 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3704
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
corn starch
Note: Inactive ingredients may vary.
More about armodafinil
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (339)
- Drug images
- Pricing & coupons
- En español
- Drug class: CNS stimulants
Patient resources
- Other brands
- Nuvigil
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.